France Grants Reimbursed Compassionate Access for BOT/BAL in Refractory MSS Colorectal Cancer

BOT/BAL-in-MSS CRC

Global Leaders in Cancer Research Join OncoDaily’s Editorial Board

Cancer research

Cemiplimab-rwlc (Libtayo) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and more

Cemiplimab-rwlc (Libtayo)

Park So Dam : From Parasite Stardom to Battling Thyroid Cancer with Strength

Park So Dam

Olivier Elemento: A Blueprint for AI Benchmarks in Cancer Research

Olivier Elemento, Data Interaction

2025 ASTRO Fellow Spotlight Series - Andrew Wang

Andrew Wang

Mostafa Faisal Shared Study on HLA-DQB1 Mismatch and Donor Age in HCT Outcomes

Mostafa Faisal Shared Study on HLA-DQB1 Mismatch and Donor Age in HCT Outcomes

Hung Trinh: Shared Peptide Vaccine Candidates in Ovarian Cancer

Hung Trinh, Pasritamig

Oncology